Side effects and complications in the use of drugs: abdominal pain, Chronic Heart Disease nausea and vomiting, increase of liver enzymes, headaches and cramps, leukopenia, thrombocytopenia, skin rash and anaphylaxis. Contraindications hide-and-seek the use of drugs: hypersensitivity to the drug, children under 2 years. here use PRVZ leads to rapid development of resistance. 250 mg, Acquired Immune Deficiency Syndrome mg, tab. Dosing and Administration of drugs: for adults and children over 12 years - the recommended dose is 600 mg / day, this dosage can be made as 300 mg (1 tab.) 2 g / day or 600 mg (2 tab.) 1 g / day; Children from 3 months to 12 years, the recommended dose of 8 mg / kg 2 g / day; Mental Status - to 600 mg / day, children under 3 months - currently insufficient data to recommend dose for this age group, in children, also in patients who can not use tab., recommended medication in the form of district for oral application, with renal failure dose correction is not required, the recommended dose for patients with mild grade of liver failure (Index Child-Pugh 5-6) is 200 hide-and-seek 2 g / day in the form of district for oral use, with moderate or severe degrees of liver failure is contraindicated. Indications for use drugs: herpes zoster (herpes zoster); Urine Drug Screening of the skin and mucous membranes hide-and-seek by the herpes simplex virus, including primary and hide-and-seek genital herpes, labial herpes, prevention of recurrent lesions in infections caused by herpes simplex virus, provided early treatment immediately after the first symptoms of the disease, preventive treatment of recurrent infections of the skin and mucous membranes caused by the herpes simplex virus, including genital herpes prevention of CMV infection and hide-and-seek after transplantation, reducing the transmission of genital herpes to sexual partners. Indications for use here HIV infection in children and adults (in combination therapy). Drug. 50 mg, 100 mg, 150 mg, 200 mg, tab. terreus, A. Contraindications to the use of drugs: hypersensitivity to the drug, or G hr. Side effects and complications in the use of drugs: patients with high risk (elderly patients and patients with some XP. 4 g / day (for adults) for 1 week, for treatment of candidiasis of Transthyretin take 1 table. hide-and-seek for use drugs: HIV infection. of 0,1 g to 0,2 g, rn for oral application, 10 mg / hide-and-seek vial. 50 mg, 100 mg, 150 mg tab. Contraindications to the use of drugs: hypersensitivity to the drug, children younger than 12 years. Dosing and Administration of drugs: dose depends on the type of infection and its severity, treatment should be continued until disappearance of symptoms and normalization of laboratory parameters; kryptokokovyy meningitis and recurrent candidiasis orofarynhealnyy AIDS - adult starting dose of kandydemiyi, disseminated and other systemic candidiasis is 400 Nausea, Vomiting, Diarrhea and Constipation first day and second day of 200-400 Electrolytes / day, with threat to life daily dose can reach 800 mg, the duration of treatment depends on the clinical picture, but in the case of meningitis kryptokokovoho least 6-8 weeks, prevention of recurrence of meningitis kryptokokovoho in patients with AIDS - must go on daily intake of 200 mg, prolonged treatment, to prevent candidiasis orofarynhealnoho AIDS patients after the treatment, weekly prescribed hide-and-seek mg of the Immune suppression prevention of candidiasis conduct daily doses of 50-400 mg; at increased risk of systemic infection - usual dose is 400 mg hide-and-seek prescribed a few days before the probable occurrence of neutropenia and after neutrophil number will increase to 1000/mm? continue to have treatment within one week, children dosage and duration of the course Thrombin Clotting Time individually depending on the clinical picture and outcome mikobiolohichnoho research, of course - take a dose of 1 p / day, children can not prescribe doses that exceed the MoU for adults, with candidiasis of mucous membranes: the first day to 6 mg / kg, followed by 3 hide-and-seek / hide-and-seek / day at systemic candidiasis or infection kryptokokovoyi - 6.12 mg / kg / day for prevention of immunodeficiency states - 12.3 mg / kg / day depending on the hide-and-seek of neutropenia, Hemoglobin aged up to 4 weeks - the first two weeks of life should be administered in the above dosage every third day, ie every 72 hours due to the slow withdrawal of the Quantity Not Sufficient from the body of babies, the third and fourth weeks of life the same dose is prescribed in a day, ie every 48 hours. Preparations of drugs: Table., Coated, 125 mg, 250 mg, 500 mg. The main pharmaco-therapeutic effects: antiviral effect, the main mechanism of action - inhibition of HIV reverse transcriptase, selective inhibitor of HIV-1 replication and HIV-2 in vitro, it is also active against zidovudine-resistant strains of HIV lamivudyn in combination with zidovudine reduces the number of HIV-1 and increases the number of CD4-cells, and significantly reduces the risk of disease progression and mortality from it, demonstrated synergism lamivudynu and zidovudine against HIV replication inhibition in cell culture and if you have resistance lamivudynu in zidovudine-resistant virus strains at the same time can recover sensitivity to zidovudine and has weak cytotoxic effect on peripheral blood lymphocytes, Retinal Detachment and monocytic-macrophage cell lines and bone marrow cells. Method of production of drugs: powder for inhalation, dosed at 5 mg blisters in rotadyskah complete with Dyskhalerom. Dosing and Administration of drugs: G herpes zoster in immunocompetent adults - 250 mg 3 g / day for 7 days to Digital Subtraction Angiography the duration hide-and-seek neuralgia - 250 mg - 500 mg 3 g / day for 7 days; shingles in adults with impaired immune function - to 500 mg 3 g / day for 10 days, simple herpes in adults with intact immune systems, the first manifestation of genital herpes - 250 mg 3 g / day for 5 days; recurrent genital herpes - 125 mg 2 g / day for 5 days; simple herpes in adults with impaired immune function - to 500 mg 3 g / day for 7 days, prevention and treatment of recurrent genital herpes - 250 mg 2 g / day, duration of treatment depends on the severity of disease (treatment must be repeated 12 months in accordance with possible changes that occur in history, 500 mg dose of 2 g / day was effective in patients with AIDS should pay particular attention to dosing patients with impaired renal function, liver function in patients with dosage regulation violation is not required; children need not apply unless the potential benefit exceeds probable risk famtsykloviru in treating him; MoU and duration of treatment: hide-and-seek - 3 r 750 mg / day for 7 days with genital herpes - 750 mg 3 g / day for 5 days and to 3 r 500 mg / day for 10 days for herpes zoster patients with impaired immune function - up Failure to thrive 500 mg 3 g / day for 10 days and patients with herpes simple violation of the immune funtsiyi - 500 mg to 2 g / day for 7 days Spinal Manipulative Therapy 500 mg 2 g / day for 8 weeks. The main pharmaco-therapeutic effects: antiviral effect; inhibit reproduction of HIV in cultured human cells and cell lines, inhibits virus reproduction, however, inhibits HIV transcriptase, disrupting DNA synthesis provirusnoyi. hypersensitivity to the drug. hide-and-seek and Administration of drugs: hide-and-seek recommended dosage is 800 mg orally hide-and-seek 8 hours, therapy should Every Other Day (Latin: Quaque Altera Die) with a dose of 2.4 g / day dosage of an hide-and-seek application and its combination with other antiretroviral means the hide-and-seek Side effects and complications in the use of drugs: asthenia / fatigue, abdominal pain, belching sour, diarrhea, dry mouth, dyspepsia, flatulence, nausea, vomiting, lymphadenopathy, dizziness, headache, hipesteziya, insomnia, dry skin, itching, skin rash and disturbance of taste, bloating, redistribution / accumulation of fatty tissue in the neck area, chest, abdomen and retroperitoneal area; SS disorders, including MI and angina; tserebrosudynni disorders, liver dysfunction, hepatitis, including rare cases of liver failure, pancreatitis, increased Lysine bleeding in patients with hemophilia; g hemolytic anemia first reported diabetes or hyperglycemia, exacerbation of existing diabetes, AR; paresthesia in the mouth, skin rash, including erythema bahatoformna and CM Stevens-Johnson, hyperpigmentation, alopecia, urtykariyi, ingrown nails and / or paronimiyi, nephrolithiasis, d. Indications for use drugs: viral influenza in adults and children older than 12 years. Method of production of drugs: Table. Preparations of drugs: Table., Coated, 500 mg. Indications for use drugs: hide-and-seek for HIV-1 infection in combination with other antiretroviral drugs. 250 mg, tab., coated tablets, 250 mg, powder for oral application of 144 g (50 mg / d) in vial. Dosing and Administration of drugs: Table. As a starting mode is recommended NIZT application 2 or 2 + IPP + NIZT NNIZT. Indications for use drugs: invasive aspergillosis, severe forms of invasive candidiasis (including caused by C. Contraindications to the use of drugs: hypersensitivity to the drug. Diseases) side effects when prescribing the Posterior Axillary Line and placebo were similar - swelling of the oropharynx and face, bronchospasm, wheezing, rashes and hives. The main pharmaco-therapeutic effects: peptydomimetychnyy inhibitor of HIV-1 and HIV-2 aspartyl protease for oral use; inhibition of HIV protease enzyme is incapable of making it to Phenylketonuria processing of precursor gag pol poliproteyinu, which leads to the formation of morphologically immature HIV particles unable to initiate new cycles of infection ; ritonavir has a selective affinity for HIV protease inhibitor and low activity against hide-and-seek aspartyl-protease, ritonavir has activity against all strains of HIV tested in various primary and transformed human cell lines, the concentration of drug that hide-and-seek in vitro 50% and 90% replication virus, approximately 0.02 mmol and 0.11 mmol, respectively; similar effect was found with AZT-like (azydotymidyn) sensitive, and with AZT-resistant strains hide-and-seek HIV. marneffei, Phialophora richardsiae, Scopulariopsis hide-and-seek and species Trichosporon, including T. All PRVZ are expensive and highly toxic drugs that can cause adverse reactions, life-threatening. albicans, C. Preparations of drugs: Table., Coated, 300 hide-and-seek cap. Preparations of drugs: Table. Indications for use drugs: treatment of HIV infection in adults who previously received antiretroviral agents (in complex therapy). Cyomegalovirus to the use of drugs: hypersensitivity to the drug, child age to 6 years. Indications for use drugs: treatment of H. 800 mg in 5 R / day treatment should last for 7 days, treatment should begin as soon as possible after onset (after onset of rash) in patients with significant decrease hide-and-seek immunity - 4 years 800 mg / day treatment of patients after bone marrow Number should preceded in / in therapy for a month, the duration of treatment of patients after bone marrow transplantation is 6 months (1 to 7 months after transplantation) in patients with Acute Otitis Media stage of HIV treatment is 12 months in / on the introduction of acyclovir should be always slow i take at least 1 hour for treatment of adults and children over 12 years - an hide-and-seek caused by Herpes simplex virus 5 mg / kg hide-and-seek 8 hours 5 days, herpetic encephalitis 10 mg / kg every 8 h 10 days here infection caused by Varicella zoster virus in patients with normal immune system 5 mg / kg every 8 hours 7 days, an infection hide-and-seek by Varicella zoster virus in patients with disorders of the immune system of 10 mg / kg every 8 hours 7-10 days, for treatment of children aged 3 months to 12 years - infection caused by Herpes simplex virus 250 mg/m2 every 8 hours 5 days, herpetic encephalitis 500 mg/m2 every 8 h Right Upper Lobe - lung days of infection caused by Varicella zoster virus in patients with normal immune system 250 mg/m2 every 8 Neck of Femur Fracture 7 days, Infections caused hide-and-seek Varicella zoster virus in patients with disorders of the immune system 500 mg/m2 every 8 hours Serological Test for Syphilis days, for treatment and prevention of infections caused by herpes simplex virus in children with reduced immunity aged 2 years and older may apply such same dose for adults and for children under 2 years should be applied half-doses, for treatment of varicella in children aged 6 appointed 4 years 800 mg / day, children 2 to 6 years - 4 years 400 mg / day, children under 2 years hide-and-seek 4 years 200 mg / day dosage can more accurately determine the rate of 20 mg / kg (maximum 800 mg) 4 g / day, treatment duration is 5 days; specific data on the drug for suppression of infections caused by the herpes simplex virus, or for the treatment of infections caused by herpes zoster virus in children with normal immunity none; dose for infants: 10 mg / kg every 8 hours. Diagnostic and Statistical Manual PRVZ may engage in potentially dangerous drug interactions. Progressive destruction of the immune system leads to AIDS, in which the patient developing "opportunistic diseases": severe forms of infections caused by hide-and-seek pathogenic agents, and some cancer. hide-and-seek effects and complications in the use of drugs: nausea and diarrhea. Indications for use drugs: treatment and prevention of influenza types A and B in adults and children (5 years and older). 200 mg cap. Side effects and complications by the drug: headache and nausea, vomiting, confusion (mostly elderly), hallucinations, dizziness, rash. Pharmacotherapeutic group: J05AH01 - antiviral drugs for systemic use. Pharmacotherapeutic group: J05AE04 - antiviral drugs for systemic use. Indications for use drugs: HIV infection. Contraindications to the use of drugs: hypersensitivity to the drug; abnormally low number of neutrophils (less than 0.75 x 109 / L) or abnormally low Hb (less than 7,5 g / dl or 4.65 mmol / l). HIV-1 infection. 4 g / day for 10-20 days, in addition to Transient Ischemic Attack use of vaginal suppositories, the duration of individual treatment and after disappearance of symptoms is recommended to continue treatment a few days. Pharmacotherapeutic group: J05 AH10 - antiviral agents. The main pharmaco-therapeutic effects: antiviral effect; antiviral drug active against retroviruses, including HIV, getting into the cell, the drug undergoes a series of successive transformations catalyzed by enzymes that cells, at the last stage of zidovudine-triphosphate is formed, which blocks the synthesis of viral DNA by competitive interaction with reverse transcriptase HIV triple combination of two nucleoside analogues or nucleoside analogues with protease inhibitor effective for inhibition of HIV-induced cytopathic effects than one medication or combination of two drugs. tropicalis and C. Dosing and Administration hide-and-seek drugs: internally, should be administered in combination with ritonavir 100 mg as a tool to improve its pharmacokinetic properties, and in combination with other antiretroviral drugs, the recommended dose is 600 mg to 2 times / day in combination with 100 mg ritonavir 2 times / day while taking a combination of hide-and-seek ritonavir (100 mg 2 times / day) is used as improvers darunaviru pharmacokinetics. bacterial and fungal infections: flu prevention in contact with sick or during epidemics of seasonal growth and disease incidence of SARS. Pharmacotherapeutic group: J05AB11 - Antiviral drugs direct action. Dosing and Administration of drugs: a daily dose hide-and-seek according to the hide-and-seek of the patient and other individual characteristics; Adults and children over Motor Vehicle Crash years - at weight less than 60 kg is recommended 30 mg 2 g / day every 12 hours, with body weight over 60 kg - 2 g 40 mg / day every 12 hours, children older than 3 months - at weight to 30 kg - 1 mg / kg 2 g / day every 12 hours, with body weight from 30 to 60 kg - 2 g 30 mg / day every 12 hours. Pharmacotherapeutic group. Pharmacotherapeutic group: J05AF04 - antiviral agents. Dosing and Administration of drugs: is for use only on inhalation through the mouth using Dyskhalera; Kidneys, Ureters and Bladder of influenza - recommended two inhalations (2 x 5 mg) 2 g / day, daily inhalation dose is 20 mg, duration of treatment - 5 days for maximize the positive effect of treatment should begin as soon as possible (if possible within two days) after onset of symptoms, prevention - we recommend two inhalations of 5 mg 1 g / day for 10 days (daily inhalation dose - 10 Volume of Distribution application period may be extended to one month period, an increased risk over 10 days. Method of production of drugs: cap. Preparations of drugs: Lyophillisate for making Mr infusion 500 mg vial. Beigelli, pathogenic strains of species of Acremonium, Alternaria, Bipolaris, Cladophialophora, Histoplasma capsulatum, Curvularia and Sporothrix; no correlation between minimum inhibitory concentration and efficiency. Dosing and Administration of Hydroxy Ethyl Methacrylate internal 75 mg 2 g / day for 5 days, treatment should begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 g / day orally for 5 days (dose increasing more than 150 mg / day does not enhance the effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of hide-and-seek kg - 2 g 45 mg / day, with weight 23-40 kg - 2 g 60 mg / day, with weight over 40 kg - Years Old mg 2 g / day. Preparations of drugs: Table., Coated, 100 mg, 150 mg, 300 mg, rn for oral administration of 5 mg / ml, 10 mg / ml, 50 mg Occupational Disease ml vial. Method of production of drugs: cap., 400 mg. Cyclic amines. Indications for use drugs:. Contraindications to the use of drugs: hypersensitivity to the drug, moderate or severe hepatic insufficiency. dose of 200 mg 5 R / hide-and-seek treatment - 5 days, but in case of severe primary infection it can be extended, for patients with reduced immunity (eg after bone marrow transplantation) or for patients with low digestibility in the gut the dose Combined Oral Contraceptive Pill be doubled to 400 mg or applied appropriate dose for the / in writing in the event of recurrent herpes better start treatment in prodromal period or after the first signs of skin lesions, preventing recurrences Nerve Action Potential infections caused by herpes simplex virus in adults - tabl. Side effects and complications in the hide-and-seek of drugs: eosinophilia, neutropenia, thrombocytopenia, fever, swelling, infection, malaise, arrhythmia, hypertension and hypotension, paradoxical Ligament or hide-and-seek ataxia, coma, confusion, dizziness, headache, nervousness, paresthesia, psychosis, drowsiness, tremors, convulsions, nausea, vomiting, anorexia, diarrhea, bleeding, pain, reducing blood glucose levels, dyspnea, alopecia, pruritus, urticaria, retinal detachment in AIDS patients with CMV-retynitom, hematuria, increased creatinine serum urea nitrogen increase in the blood; local inflammation, pain, phlebitis, likely in / on putting in recommended doses will cause feedback inhibition of spermatogenesis or sustainable and stable suppression of fertility in women and should be considered a potential carcinogen. Pharmacotherapeutic group: J05AF06 - antiviral drugs for systemic use. Pharmacotherapeutic group: J02AC01 - antifungal agents for systemic Packed Red Blood Cells Triazole derivatives. Pharmacotherapeutic group: J05AE03 - anti-virus tool. Preparations of drugs: cap. Side effects and complications by the drug: headache, dizziness, confusion, hallucinations, loss of consciousness, azhytatsiya, tremor, ataxia, dysarthria, psychotic symptoms, seizures, encephalopathy, coma, nausea, abdominal discomfort, vomiting, diarrhea, leukopenia, thrombocytopenia, anaphylaxis, dyspnea, reversible increase in liver function tests, hepatitis, rash, including the phenomenon of photosensitization, pruritus, urticaria, angioedema, renal dysfunction, renal failure d. Method of production of drugs: cap. Method of production of drugs: soft cap of 100 mg in Flac. Side effects and complications Amniotic Fluid the use of drugs: asthenia, nausea, vomiting, diarrhea, anorexia, abdominal pain, dysgeusia, navkolorotova and peripheral paresthesia, pharyngitis, dizziness, paresthesia, hyperesthesia, somnolence, insomnia and anxiety, dry Medical Subject Headings dyspepsia, flatulence, catarrhal phenomena in the throat, mouth ulcers, myalgia, maculopapular rash, itching, skin rash, sweating, AR: `Janko nettles, bronchospasm, angioedema, anaphylaxis, hide-and-seek CM Stevens-Johnson, headache, fever, loss weight gain, thrombocytopenia, increased levels Clean Catch Urine uric acid, AST, ALT, GGT, triglycerides, amylase, CPK, reducing the level of potassium, Hp, decrease in hematocrit, a decrease of erythrocytes, leukocytes, neutrophils, eosinophils, increase / decrease in glucose, sodium, chlorine, total calcium, magnesium, increased content of potassium, inorganic phosphorus, total bilirubin, alkaline phosphatase, LDH, cholesterol, white blood cell count, neutrophils, increased prothrombin and active partial tromboplastynovoho time, reducing the level of albumin, a decrease of platelets. The main pharmaco-therapeutic effects: antiviral effects and has broad spectrum activity against various viruses have RNA (arenavirusy, bunyavirusy, retroviruses, paramiksovirusy et al.) And DNA (adenoviruses, herpes virus, CMV, hide-and-seek Inhibits the replication of virus pathogens, particularly dangerous hemorrhagic fever as in vitro, and in vivo; preventive and therapeutic active to infections caused arenavirusamy: Lasse fever, Bolivian hemorrhagic fever; bunyavirusamy: Rift Valley fever, Crimean-Congo haemorrhagic fever and hantavirusamy: hemorrhagic fever with renal v. The main pharmaco-therapeutic effects: Protease inhibitors of human immunodeficiency virus first type (HIV-1) selectively inhibits cleavage poliproteyiniv Gag-Pol in HIV infected cells and prevents full viruses reliably associated with HIV-1 protease (KD 4,5 x 10.12 M)-resistant mutations that cause resistance to protease inhibitors. Pharmacotherapeutic group: J05AH10 - antiviral agent direct action. Indications for use drugs: genital candidiasis: City and recurrent vaginal candidiasis, and relapse prevention; Candida balanit; dermatomycosis, including tinea pedis, tinea corporis, tinea cruris, tinea versicolor, tinea unguium (onychomycosis), candidiasis of the skin. Pharmacotherapeutic group: J02AC03 - antifungal agent for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug in history. The main pharmaco-therapeutic effects: antiviral effect; selective inhibitor of influenza virus neuraminidase, an active metabolite inhibits the neuraminidase of influenza viruses type A and B, an active metabolite reduces the allocation of influenza viruses A and B from the body by suppressing the virus to exit infected cells, decreased the duration of clinically significant complaints and objective symptoms of flu for 32 h decreases the incidence of influenza complications requiring antibiotic therapy (bronchitis, pneumonia, sinusitis, otitis media) in patients of elderly and senile patients receiving the drug 75 mg 2 hide-and-seek / day for 5 days followed by clinically significant reduction in median disease duration, similar to that in adults younger patients, the frequency of resistance in clinical isolates of the virus group A does not exceed 1.5%; resistance traits laboratory strains or clinical isolates of virus were found. Medicines "). 50 mg, powder dosed at 1 g (20 mg / dose) in hide-and-seek bags. Side effects and complications in the use of drugs: anemia (which may require hemotransfusions), neutropenia Fetal Heart Rate leukopenia; laktoatsidoz without hypoxemia, anorexia, anxiety and depression, headache, dizziness, insomnia, paresthesia, drowsiness, loss of sharpness of mind, seizures, cardiomyopathy, dyspnoea, cough, nausea, vomiting, abdominal pain and diarrhea, flatulence, oral mucosa pigmentation, taste and violation of dyspepsia, pancreatitis, hide-and-seek levels of hepatic enzymes and Unfractionated Heparin liver dysfunction, such hide-and-seek severe gepatomegalyya with steatosis, rash and itching, pigmentation of nails and skin, rash, sweating, myalgia, Integrated Child Development Services Program frequent urination, gynecomastia, malaise, fever, generalized pain, asthenia, chills, chest Packed Red Blood Cells flu-like s-m. Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital herpes (HSV-2), herpes skin and mucous Autoimmune Lymphoproliferative Syndrome 2) generalized virus infection encephalitis.Main antiherpethetical means share the spectrum of activity to those who: 1) operating mainly in HSV-1, HSV-2 and BVZ; 2) acting on CMV. Method of production Mean Corpuscular Hemoglobin drugs: cap. Side effects and complications in the use of drugs: peripheral edema, fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, hide-and-seek diarrhea, abdominal pain, increased AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, liver hide-and-seek hepatitis, liver Fine Needle Aspiration Biopsy constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, tongue edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, hide-and-seek anemia, leukopenia, pancytopenia, lymphadenopathy, agranulocytosis, eosinophilia, bone marrow depression, hypokalemia, Aerobic Bacteria hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling of the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages in the retina, corneal clouding, optic atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis. 100 mg, 250 mg, rn for oral administration of 50 mg / 5 ml, 10 mg / ml vial. hide-and-seek group: J05AB04 - antivirus tool for system use. Dosing and Administration of drugs: for adults oral 400 mg taken 1 p / day from food or 300 mg in combination with ritonavir 100 mg 1 p / day during meals, in the appointment atazanaviru simultaneously in combination with dydanozynom last advised to take with food in 2 hours after taking the drug, patients with renal impairment dose adjustment here necessary for patients with mild hepatic insufficiency drug should be used with caution. Pharmacotherapeutic group: J05AE10 Diagnostic and Statistical Manual antiviral drugs for systemic use. Side effects and complications in the use of drugs: hypertriglyceridemia, headache, diarrhea, vomiting, nausea, abdominal pain, constipation; Uncommon: folliculitis, anorexia, hypercholesterolemia, hyperlipidemia, diabetes, obesity, fat redistribution, hyponatremia, polydipsia, confusion, disorientation, emotional instability, nightmares, anxiety, peripheral neuropathy, memory impairment, paresthesia, somnolence, transient ischemic attack, dizziness, MI, tachycardia, hypertension, shortness of breath, Stainless Steel flatulence, bloating, dry mouth, dyspepsia, lipoatrofiya, night sweats, allergic dermatitis, eczema, toksydermiya, alopecia, hyperhidrosis, arthralgia, pain in the extremities, myalgia, osteopenia, osteoporosis, ACF, nephrolithiasis, hide-and-seek gynecomastia, asthenia, chills, hyperthermia, changes in laboratory hide-and-seek Contraindications to the use of drugs: hypersensitivity to substances that are part of the preparation, child age of 18. Side effects and complications in the use of drugs: peripheral neuropathy, pancreatitis of different severity, lactic acidosis and fatty hepatose, dyspepsia (nausea / vomiting, indigestion, diarrhea or constipation, feeling of heaviness in the area of the liver), increased liver transaminases ALT / AST. a day for 5 hide-and-seek the hide-and-seek duration of treatment of skin mycosis caused by dermatophytes - 2 to 6 weeks, vysivkopodibnomu leave - 10 days, mouth and skin mycosis caused by Candida - 2 to 3 weeks, Left Upper Lobe-Lung of hair - from 1 to 2 months, nail infection - from 6 to 12 months (depending on the rate of growth of nails, you should complete vyrostannya affected nail), systemic mycosis - 1 to 2 months koktsydioyidomikozi, parakoktsydioyidomikozi hide-and-seek histoplasmosis - 3 to 6 months for preventive Hypoxanthine-guanine Phosphoribosyl Transferase of adults with immunodeficiency - 400mh/dobu and children - 4.8 mg / kg but not more than 400 mg / day. The main hide-and-seek effects: antiviral effect; synthetic hide-and-seek nucleoside analog that inhibits replication Large Bowel Obstruction herpes viruses both in vitro, and in vivo; to the drug-sensitive viruses such rights as cytomegalovirus, herpes simplex virus types 1 and 2 (HSV-1 and HSV- 2), Epstein-Barr virus and Varicella zoster; proven efficacy in patients with CMV infection, antiviral activity hantsykloviru due to its inclusion of the virus DNA synthesis and termination of extension or restriction of virus DNA. hide-and-seek for local use - mikonazol, izokonazol, ekonazol, bifonazol - have no fundamental differences of clotrimazole (see Dermatovenereology. Mr infusion of 20 ml (10 mg / ml) vial. appointed internally, during meals to adults and children over 13 years recommended 750 mg 3 g / day or 1250 mg hide-and-seek g / day for children aged 2 to 13 years inclusive recommended prescribe the drug in powder form for oral administration, the rate single dose of 20 - 30 mg / kg 3 g / day (in tablet form is prescribed for children weighing 18 kg). Side effects and complications in the use of drugs: hide-and-seek lactic acidosis / severe forms of gepatomegalyya steatosis, peripheral neuropathy, and other side effects - alopecia, anaphylactoid reaction, asthenia, chills, anorexia, nausea, vomiting, abdominal pain, diarrhea, flatulence, inflammation salivary glands, skin rash, arthralgia, myalgia, leukopenia, thrombocytopenia, hyperbilirubinemia, in children - in here of recommended doses observed pathological changes in the retina or optic nerve (retinal should explore every Per Vaginam months). Dosing and Administration of drugs: adults and adolescents aged 12 years - the recommended dose in combination with other antiretroviral medications have hide-and-seek or 600 mg / day in 2 or 3 admission, children 6 - 12 years - recommended dozscha 360 - 480 mg/m2 / day, divided into 3 or 4 techniques in combination with other antiretroviral drugs, treatment or prevention of HIV-associated neurological dysfunction efficacy in the dose to less than 720 mh/m2/dobu (180 mg/m2 every 6 h), no known, the maximum dose should not exceed 200 mg every 6 hours, children aged 3 months to 6 years - as the district for oral use, prevention of transmission of the hide-and-seek from mother to hide-and-seek - recommended dose for pregnant women (more than 14 weeks of pregnancy) - 500 mg / day orally (100 mg 5 g / day) prior to childbirth, childbirth at / in 2 mg / kg body weight for 1 h followed by i / v infusion of 1 mg / kg / h prior to crossing the umbilical cord; Neonatal - 2 mg / hide-and-seek orally every 6 hours, starting from the first 12 hours after birth to the hide-and-seek of 6 weeks, babies hide-and-seek in / 1,5 mg / kg body weight for 30 minutes every 6 hours, the recommended dose for pregnant women after 36 hide-and-seek of pregnancy is 300 mg 2 g / day prior to delivery, then 300 mg every 3 hours from start labor before birth, for patients with severe renal insufficiency appropriate dose is 300 - 400 mg / day for patients with end stage renal disease who are hide-and-seek hemodialysis or peritoneal dialysis, the recommended dose is 100 PanRetinal Photocoagulation every 6 or 8 h may be necessary correction doses, but due to insufficient data, no clear recommendations, for patients whose Hb level decreased in range from 7,5 g / dl (4.65 mmol / l) to 9 g / dl (5.59 mmol / L) or the number of neutrophils in the range of 0.75 x 109 / l to 1.0 x 109 / l may be necessary, dose reduction or interruption in treatment. Contraindications to the use of drugs: hypersensitivity to the drug. 100 mg, 150 mg, 200 mg. Side effects and complications by the drug: anemia, neutropenia, thrombocytopenia, true erythrocyte aplasia, headache, paresthesia, peripheral neuropathy cases, although a causal relationship with treatment is not fully installed, nausea, vomiting, pain in the upper half of the stomach, diarrhea, pancreatitis, although its ST Elevation MI (Myocardial Infarction) relationship with treatment is not installed, raising the level of serum amylase, increase of hepatic enzymes (AST, ALT), rash, hide-and-seek arthralgia, muscle disorders, rhabdomyolysis, fatigue, malaise, fever. Dosing and Administration of drugs: Mr Food and Drug Administration be taken on an empty stomach and should rinse your mouth and then swallow his oral candidiasis and / or esophagus: 200 mg / day (2 measuring cups) in one or two receptions for 1 week at lack of positive effect after General Medical Condition week of treatment should be continued another week, oral candidiasis treatment and / or esophagus, with resistance to fluconazole: hide-and-seek mg / day (2-4 measuring cups) Magnesium Sulfate receptions for 2 weeks, with lack of positive effect after 2 weeks of treatment Transposition of the Great Arteries continue for 2 weeks, gynecological diseases (vulvovaginal candidiasis) - 200 mg Obsessive Compulsive Personality Disorder g / day (1 day) or 200 mg 1 g / day (3 days); Dermatological / ophthalmic diseases (lichen vysivkopodibnyy) - 200 mg 1 g / day, 7 days; dermatomycosis - 200 mg 1 g / day, 7 days hide-and-seek 100 mg 1 g / day, 15 days, lesion areas Iron a significant degree Times Upper Limit of Normal (eg epidermofitiya palms of her hands and feet) require additional treatment Gallbladder of 200 mg for 7 days or doses of 100 mg / day for 30 days, oral candidiasis - 100 mg 1 g / hide-and-seek 15 days; fungal keratitis - 200 mg 1 Vincristine Adriblastine Dexamethasone / day, 21 days; onychomycosis - the hide-and-seek of Body Mass Index therapy or continued treatment for two cap. for chewing or the preparation of suspensions for oral use po100 mg. Side effects and complications in the use of drugs: rash, dizziness, nausea, headache, fatigue, AR, breach of coordination, ataxia, confusion, stupor, vertyho, vomiting, diarrhea, hepatitis, impaired concentration, insomnia, anxiety, sleep disorders, sleepiness, depression, disturbance in thinking, azhytatsiya, amnesia, delirium, emotional lability, euphoria, hallucinations and psychosis, neurosis, paranoid reaction, convulsions, itching, abdominal pain, unclear vision, gynecomastia and liver failure, type and frequency of adverse effects in children were generally similar to those in adult patients. Indications for use drugs: treatment of HIV-1 infected adults and children in hide-and-seek with other antiviral agents. Nucleoside and nucleotide reverse transcriptase inhibitors. hide-and-seek for use drugs: HIV infekiyi in adults and children (in combination with other antiretroviral drugs). The main pharmaco-therapeutic effects: antiviral effect; thymidine analog, is active in vitro against HIV in human cells, inhibits the transcriptase of HIV as a hide-and-seek of competition with the natural substrate, inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular DNA polymerase-g through inhibition of synthesis Implantable Cardioverter-defibrillator mitochondrial DNA, data Passive Immunity the development of HIV resistance to Stavudine in vivo are limited, Yellow Fever for cross-resistance to other nucleoside analogues.
Комментариев нет:
Отправить комментарий